Exploring the Link Between GLP-1 and Hair Loss While GLP-1 medications demonstrate a positive impact on weight management and blood sugar control, the emergence of hair loss as a potential side effect has caused concern among some individuals
S.MacPhersonL.et al (2012)
While PAP may be beneficial in a subset of patients with OSA, emerging preclinical and clinical data suggest it may potentially cause harm in others [27], particularly at higher pressures [28], though this requires rigorous validation in future studies
Trials with older GLP-1 drugs (liraglutide, exenatide) including the large ADJUNCT ONE and ADJUNCT TWO studies showed modest HbA1c improvements of 0.10.7%, meaningful weight loss, and lower insulin requirements, but also raised early concerns about hypoglycemia and ketosis that kept enthusiasm in check for years
Ash: The Foundation for Clinically Rigorous Scale Ash delivers the necessary infrastructure for consumer platforms that demand clinically rigorous data, operational scale, and seamless integration